Abstract
The MT1 melatonin receptor is bound and activated by the pineal hormone melatonin. This G protein-coupled melatonin receptor is expressed in human breast tumor cell lines, and when activated, mediates the growth-suppressive and steroid hormone/nuclear receptor modulatory actions of melatonin on breast tumor cells. In the current studies, we have examined the expression of the MT1 receptor in breast cancer cell lines and primary human breast tumors and correlated MT1 receptor expression with the deletion, rearrangement and amplification of the MT1 gene and established markers of breast cancer such as tumor size, stage, estrogen receptor alpha (ERα) and progesterone receptor (PR) expression. Theses studies suggest amplification of the MT1 gene in some breast tumors and an inverse correlation with ERα, PR and MT1 protein expression. Furthermore, these approaches employing immunohistochemical and immunofluorescent/confocal microscopic studies demonstrate that the MT1 receptor is localized to the caveoli and that MT1 expression in MCF-7 breast cancer cells can be repressed by estradiol and melatonin.
Similar content being viewed by others
References
Hill SM, Blask DE (1988) Effects of the pineal hormone on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 48:6121–6126
Ram PT, Dai J, Dong C, Kiefer TL, Lai L, Hill SM (2002) Involvment of the MT1 melatonin receptor in human breast cancer. Cancer Lett 179:141–150. doi:10.1016/S0304-3835(01)00873-4
Kiefer TL, Ram PT, Yuan L (2002) Hill: melatonin inhibits estrogen receptor transactivation and cAMP levels in breast cancer cells. Breast Cancer Res Treat 71:37–45. doi:10.1023/A:1013301408464
Ross AW, Webster CA, Thompson M, Barrett P, Morgan PJ (1998) A novel interaction between inhibitory melatonin receptors and protein kinase C-dependent signal transduction in ovine pars tuberalis cells. Endocrinology 139:1723–1730. doi:10.1210/en.139.4.1723
Giland E, Matzkin H, Zisapel N (1997) Inactivation of melatonin receptors by protein kinase C in human prostate epithelial cells. Endocrinology 138:4255–4261. doi:10.1210/en.138.10.4255
Giland E, Laufer M, Matzkin H, Zisapel N (1999) Melatonin receptors in PC3 human prostate tumor cells. J Pineal Res 26:211–220. doi:10.1111/j.1600-079X.1999.tb00586.x
Slaugenhaupt SA, Roca AL, Liebert CB, Altherr MR, Gusella JF, Reppert SM (1995) Mapping of the gene for the Mel1a-melatonin receptor to human chromosome 4 (MTNR1A) and mouse chromosome 8 (Mtnr1a). Genomics 27:355–357. doi:10.1006/geno.1995.1056
Reppert SM, Godson C, Mahle CD, Weaver DR, Slaugenhaupt SA, Gusella JF (1995) Molecular characterization of a second melatonin receptor expressed in human retina and brain: the Mel1B melatonin receptor. Proc Natl Acad Sci USA 92:8734–8738. doi:10.1073/pnas.92.19.8734
Reppert SM, Weaver DR, Ebisawa T (1994) Cloning and characterization of a melatonin receptor that mediates reproductive and circadian responses. Neuron 1:1177–1185. doi:10.1016/0896-6273(94)90055-8
Dubocovich ML, Masana MI, Iacob S, Sauri DM (1997) Melatonin receptor antagonists that differentiate between the mel1a and mel1b recombinant subtypes are used to assess the pharmacological profile of the rabbit retina ML1 presynaptic heteroreceptor. Naunyn Schmiedebergs Arch Pharmacol 355:365–375. doi:10.1007/PL00004956
Godson C, Reppert SM (1997) The Mel1a melatonin receptor is coupled to parallel signal transduction pathways. Endocrinology 138:397–404. doi:10.1210/en.138.1.397
Brydon L, Roka F, Petit L, de Copet P, Tissot M, Barrett P, Morgan PJ, Nanoff C, Strosberg AD, Jockers R (1999) Dual signaling of human Mel1a melatonin Receptors via Gi2, Gi3, and Gq/11 proteins. Mol Endocrinol 13:2025–2037. doi:10.1210/me.13.12.2025
Ram PT, Kiefer T, Silverman M, Song Y, Brown GM, Hill SM (1998) Estrogen receptor transactivation in MCF-7 breast cancer cells by melatonin and growth factors. Mol Cell Endocrinol 141:53–64. doi:10.1016/S0303-7207(98)00095-1
Dillon D, Easley SE, Asch BB, Cheney RT, Brydon L, Jockers R, Winston JS, Brooks JS, Hurd T, Asch HL (2002) Differential expression of high-affinity melatonin receptors (MT1) in normal and malignant human breast tissue. Am J Clin Pathol 118:451–458
Yuan L, Collins AR, Dai J, Dubocovich ML, Hill SM (2002) MT1 melatonin receptor over expression enhances the growth suppressive effect of melatonin in human breast cancer cells. Mol Cell Endocrinol 192:147–156. doi:10.1016/S0303-7207(02)00029-1
Teplitzky SR, Kiefer TL, Cheng Q, Dwivede PD, Moroz K, Myers L, Anderson M, Collins A, Dai J, Yuan L, Spriggs LL, Blask DE, Hill SM (2001) Chemoprevention of NMU-induced rat mammary carcinoma with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett 168:155–163. doi:10.1016/S0304-3835(01)00548-1
Nowfar S, Teplitzky SR, Melancon K, Kiefer TL, Cheng Q, Dwived PD, Bischoff ED, Moroz K, Anderson M, Dai J, Lai L, Yuan L, Hill SM (2002) Tumor prevention by 9-cis-retinoic acid in the N-nitroso-N-methylurea model of mammary carcinogenesis is potentiated by the pineal hormone melatonin. Breast Cancer Res Treat 72:33–43. doi:10.1023/A:1014912919470
Melaoncon K, Cheng Q, Kiefer TL, Dai J, Lai L, Dong C, Yuan L, Collins A, Thiyagarajay A, Long S, Hill SM (2005) Regression of NMU-induced mammary tumors with the combination of melatonin and 9-cis-retinoic acid. Cancer Lett 227:39–48. doi:10.1016/j.canlet.2005.01.005
Molis T, Walters M, Hill SM (1993) Melatonin modulation of estrogen receptor expression in MCF-7 human breast cancer cells. Int J Oncol 3:687–694
Edidin M (2003) The state of lipid rafts: from model membranes to cells. Ann Rev Biopphys Biomol Struct 32:257–283. doi:10.1146/annurev.biophys.32.110601.142439
Simmons K, Toomre D (2000) Lipid rafts and signal transduction. Nat Rev Mol Cell Biol 1:31–39. doi:10.1038/35036052
Siu SWF, Lau KW, Tam PC, Shu SYW (2002) Melatonin and prostate cancer cell proliferation: interplay with castration, epidermal growth factor, and androgen sensitivity. Prostate 52:106–122. doi:10.1002/pros.10098
Morcuende JA, Minhas R, Dolan L, Stevens J, Beck J, Wang K, Weinstein SL, Sheffield V (2003) Allelic variants of human melatonin 1A receptor in patients with familial adolescent idiopathic scoliosis. Spine 28:2025–2028. doi:10.1097/01.BRS.0000083235.74593.49
Hernandez X, Bodin L, Chesneau D, Buillaume D, Allain D, Chemineau P, Malpaux B, Migaud M (2005) Relationship between MT1 melatonin receptor gene polymorphism a seasonal physiologic responses in Ile-de-France4 ewes. Reprod Nutr Dev 45:151–162. doi:10.1051/rnd:2005012
Pelletier J, Bodin L, Hanocq E, Malpaux B, Teyssier J, Thimonier J, Chemineau P (2000) Association between expression of reproductive seasonality and alleles of the gene for Mel la receptor in the ewe. Biol Reprod 62:1096–1101. doi:10.1095/biolreprod62.4.1096
Ebisawa T, Kajimura N, Uchiyama M, Katoh M, Sekimoto M, Wantanabe T, Ozeki Y, Ikeda M, Jodi T, Sagushita M, Iwase T, Kamei Y, Kim K, Shibui K, Kodo Y, Yamada N, Toyoshima R, Okawa M, Takahashi K, Yamauchi T (1999) Allelic variants of human melatonin 1a receptor: function and prevalence in subjects with circadian rhythm sleep disorders. Biochem Biophys Res Commun 262:832–837. doi:10.1006/bbrc.1999.1308
Hill SM, Muraoka H, Spriggs LL, Blask DE (1992) The growth inhibitory action of melatonin on human breast cancer cells is linked to the estrogen response system. Cancer Lett 64:249–256. doi:10.1016/0304-3835(92)90050-6
Mao L, Yuan L, Hill SM (2006) Inhibition of cell proliferation and blockade of cell invasion by melatonin in human breast cancer cells mediated through multiple signaling pathways. 97th Annual Mtg. American Association for Cancer Research, Abst. #495, Washington, D.C., 2006
Del Rio B, Garcia-Pedrero JM, Martinez-Campa C, Zuazua P, Lazo PS, Ramos S (2004) Melatonin: An endogenous specific inhibitor of estrogen receptor alpha via calmodulin. Biol Chem 279:38294–38302. doi:10.1074/jbc.M403140200
Gerdin MJ, Masana MI, Ren D, Miller RJ, Dubocovich ML (2003) Short-term exposure to melatonin differentially affects the functional sensitivity and trafficking of the hMT1 and hMT2 melatonin receptors. J Pharmacol Exp Ther 304:931–939. doi:10.1124/jpet.102.044990
Dai J, Inscho EW, Yuan L, Hill SM (2002) Modulation of intracellular calcium and calmodulin by melatonin in MCF-7 human breast cancer cells. J Pineal Res 32:1–8. doi:10.1034/j.1600-079x.2002.1844.x
Barrett P, Messager S, Schuster C, Moar KM, Mercer JG, Morgan PJ (2002) Pituitary adenylate cyclase-activating polypeptide acts as a paracrine regulator of melatonin-responsive cells of the ovine pars tuberalis. Endocrinology 143:2366–2375. doi:10.1210/en.143.6.2366
Guerrero HY, Gauer F, Schuster C, Pevet P, Masson-Pevet M (2000) Melatonin regulates the mRNA expression of the mt1 melatonin receptor in the rat pars tuberalis. Neuroendocrinology 71:163–169. doi:10.1159/000054533
Hazelrigg DG, Gonalez-Brito A, Lawson W, Hastings MH, Morgan PJ (1993) Prolonged exposure to melatonin leads to a time-dependent sensitization of anenylate cyclase and down-regulates melatonin receptors in pars tuberalis cells from ovine pituitary. Endocrinology 132:285–292. doi:10.1210/en.132.1.285
Acknowledgments
This work was supported by NIH grant CA-054152-14 to S.M.H. and P50 CA58183 to CKO at Baylor Breast Center.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lai, L., Yuan, L., Cheng, Q. et al. Alteration of the MT1 melatonin receptor gene and its expression in primary human breast tumors and breast cancer cell lines. Breast Cancer Res Treat 118, 293–305 (2009). https://doi.org/10.1007/s10549-008-0220-1
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10549-008-0220-1